Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of sunitinib in metastatic non-clear cell renal cancer
2009-010672-16Phase 2Completed
- Sponsor
- Humanitas Research Hospital
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sunitinib in non-clear cell renal cell carcinoma (nccRCC), sponsored by Humanitas Research Hospital. Primary endpoint: Progression-free survival. Started Nov 2009; status: completed.
02
Drugs
sunitinib
03
Conditions
non-clear cell renal cell carcinoma (nccRCC)
Beyond the preview
Go deeper on 2009-010672-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010672-16.